IPO: Innova Captab may be a good buy after a post-listing review

The promoters Manoj Kumar Lohariwala and his brother Vinay Kumar Lohariwala are diluting their stakes from 67% to 52%. Of the issue proceeds, ₹168 crore would be used toward debt repayment and ₹72 crore for working capital requirements.

Related Keywords

Afghanistan ,India ,Kenya ,Sri Lanka ,Haryana ,Vinay Kumar Lohariwala ,Manoj Kumar Lohariwala ,Sharon Bio ,Intelligence Group ,Harun Health Care ,Innova Captab ,Sharon Bio Medicine ,Growth Prospects ,Adding Sharon ,Windlas Biotech ,Ipo ,Promoters ,Debt ,Working Capital ,Markets ,